The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-14 of 14 articles
Invasive cardiovascular needs in South Africa: a view from afar up close
Holmes D,
King S,
Gershlick A,
Marco J,
Koolen J,
Pichard A,
Bassand J-P,
Kettles D,
Wijns W,
Ntsekhe M
October 19, 2018 | 10.4244/EIJV14I8A153
Magmaris preliminary recommendation upon commercial launch: a consensus from the expert panel on 14 April 2016
September 18, 2016 | 10.4244/EIJV12I7A137
Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial
Haude M,
Erbel R,
Erne P,
Verheye S,
Degen H,
Vermeersch P,
Weissman N,
Prati F,
Bruining N,
Waksman R,
Koolen J
June 10, 2016 | 10.4244/EIJ-D-15-00371
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data
Bourantas C,
Serruys P,
Nakatani S,
Zhang Y-J,
Farooq V,
Diletti R,
Ligthart J,
Sheehy A,
van Geuns R,
McClean D,
Chevalier B,
Windecker S,
Koolen J,
Ormiston J,
Whitbourn R,
Rapoza R,
Veldhof S,
Onuma Y,
Garcia-Garcia H
November 20, 2015 | 10.4244/EIJY14M10_06
Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Teeuwen K,
Van den Branden B,
Koolen J,
van der Schaaf R,
Henriques J,
Thijssen J,
Kelder J,
Vermeersch P,
Rensing B,
Suttorp MJ
March 20, 2015 | 10.4244/EIJY14M08_07
Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial
Bourantas C,
Farooq V,
Zhang Y-J,
Muramatsu T,
Gogas B,
Thuesen L,
McClean D,
Chevalier B,
Windecker S,
Koolen J,
Ormiston J,
Whitbourn R,
Dorange C,
Rapoza R,
Onuma Y,
Garcia-Garcia H,
Serruys P
March 20, 2015 | 10.4244/EIJY14M04_11
Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
Serruys P,
Onuma Y,
Garcia-Garcia H,
Muramatsu T,
van Geuns R,
De Bruyne B,
Dudek D,
Thuesen L,
Smits P,
Chevalier B,
McClean D,
Koolen J,
Windecker S,
Whitbourn R,
Meredith I,
Dorange C,
Veldhof S,
Hebert K,
Rapoza R,
Ormiston J
March 20, 2014 | 10.4244/EIJV9I11A217
Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI
Brener S,
Dambrink J-H,
Maehara A,
Chowdhary S,
Gershlick A,
Généreux P,
Koolen J,
Mehran R,
Fahy M,
Gibson CM,
Stone G
February 20, 2014 | 10.4244/EIJV9I10A201
Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III): a randomised comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Van den Branden B,
Teeuwen K,
Koolen J,
van der Schaaf R,
Henriques J,
Thijssen J,
Kelder J,
Vermeersch P,
Rensing B,
Suttorp MJ
November 29, 2013 | 10.4244/EIJV9I7A138
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials
Gogas B,
Bourantas C,
Garcia-Garcia H,
Onuma Y,
Muramatsu T,
Farooq V,
Diletti R,
van Geuns R,
De Bruyne B,
Chevalier B,
Thuesen L,
Smits P,
Dudek D,
Koolen J,
Windecker S,
Whitbourn R,
McClean D,
Dorange C,
Miquel-Hebert K,
Veldhof S,
Rapoza R,
Ormiston J,
Serruys P
October 25, 2013 | 10.4244/EIJV9I6A115
Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial
Brugaletta S,
Gomez-Lara J,
Bruining N,
Radu M,
van Geuns R,
Thuesen L,
McClean D,
Koolen J,
Windecker S,
Whitbourn R,
Oberhauser J,
Rapoza R,
Ormiston J,
Garcia-Garcia H,
Serruys P
July 27, 2012 | 10.4244/EIJV8I3A54
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study
Gomez-Lara J,
Diletti R,
Brugaletta S,
Onuma Y,
Farooq V,
Thuesen L,
McClean D,
Koolen J,
Ormiston J,
Windecker S,
Whitbourn R,
Dudek D,
Dorange C,
Veldhof S,
Rapoza R,
Regar E,
Garcia-Garcia H,
Serruys P
June 27, 2012
European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club
Di Mario C,
Werner G,
Sianos G,
Galassi A,
Büttner J,
Dudek D,
Chevalier B,
Lefèvre T,
Schofer J,
Koolen J,
Sievert H,
Reimers B,
Fajadet J,
Colombo A,
Gershlick A,
Serruys P,
Reifart N
May 22, 2007
Latest news
NEW ISSUE
A TAVI in Bicuspid Anatomies; TMVI; Bailout-TEER or Medical Therapy; DRT following LAAO; Cost-Effectiveness of FFR-Guided MVD Revascularisation in STEMI and more
June 24, 2022
AHEAD OF PRINT
Bioprosthetic dysfunction of the LOTUS valve
FREE ARTICLE - Rutger-Jan Nuis et al
June 17, 2022
AHEAD OF PRINT
Coronary access after ViV-TAVI with ACURATE neo2
FREE ARTICLE - Arif A. Khokhar et al.
June 16, 2022
AHEAD OF PRINT
Prognostic value of structural and functional microvascular dysfunction
FREE ARTICLE - Coen K.M. Boerhout et al
June 13, 2022
AHEAD OF PRINT
TAVR with the ACURATE neo2
FREE ARTICLE - Andrea Scotti et al
June 8, 2022
AHEAD OF PRINT
Antithrombotic strategy selection using smartphone technology
FREE ARTICLE - Jaya Chandrasekhar et al
June 3, 2022
AHEAD OF PRINT
The fingerprints of plaque rupture healing as detected by serial OCT imaging
FREE ARTICLE - Rocco Vergallo et al
June 2, 2022